NJ AR30 | 2016-2017 | Regular Session
Note: Carry Over of previous AR130
Status
Completed Legislative Action
Spectrum: Partisan Bill (Democrat 2-0)
Status: Passed on February 15 2017 - 100% progression
Action: 2017-02-15 - Filed with Secretary of State
Text: Latest bill text (Introduced) [HTML]
Spectrum: Partisan Bill (Democrat 2-0)
Status: Passed on February 15 2017 - 100% progression
Action: 2017-02-15 - Filed with Secretary of State
Text: Latest bill text (Introduced) [HTML]
Summary
Urges US FDA to reconsider approval of Zohydro ER pending comprehensive testing.
Title
Urges US FDA to reconsider approval of Zohydro ER pending comprehensive testing.
Sponsors
Roll Calls
2017-02-15 - Assembly - Assembly Floor: Third Reading - Final Passage (Y: 51 N: 1 NV: 28 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2017-02-15 | Assembly | Filed with Secretary of State |
| 2017-02-15 | Assembly | Resolution Passed Assembly (51-1-16) |
| 2016-01-27 | Assembly | Introduced, 1st Reading without Reference, 2nd Reading |
Same As/Similar To
AR130 (Carry Over) 2014-06-05 - Introduced, Referred to Assembly Health and Senior Services Committee
Subjects
New Jersey State Sources
| Type | Source |
|---|---|
| Summary | https://www.njleg.state.nj.us/bill-search/2016/AR30 |
| Text | https://pub.njleg.gov/Bills/2016/AR/30_I1.HTM |
| Roll Call | https://www.njleg.state.nj.us/bills/BillView.asp?BillNumber=AR30 |
